Stress-adaptation in obesity-associated pancreatic cancer
肥胖相关胰腺癌的压力适应
基本信息
- 批准号:9577297
- 负责人:
- 金额:$ 35.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdenocarcinoma CellAllograftingAwarenessBiomechanicsCancer EtiologyCellsCessation of lifeChemopreventionChemopreventive AgentCytoplasmic GranulesDataDeath RateDevelopmentDietDiseaseEstersGeneticGoalsGrowthGrowth FactorGrowth Factor ReceptorsHumanHypoxiaIn VitroIncidenceInflammatoryInsulinIntraepithelial NeoplasiaKRAS2 geneLesionMalignant NeoplasmsMalignant neoplasm of pancreasMediatingMediator of activation proteinModelingMolecularNutrientObese MiceObesityObesity associated cancerOrganellesPancreasPancreatic Ductal AdenocarcinomaPathway interactionsPlayResistanceRiskRisk FactorsRoleSTAT proteinSignal TransductionStimulusStressStress and CopingSurvival RateTestingTimeTumor SuppressionTumor Suppressor ProteinsUp-Regulationcancer cellcancer diagnosiscancer riskcoping mechanismexperimental studyfitnessin vivoinflammatory markerinsulin mediatorsmortalitymouse modelmutantnovelobesity developmentpandemic diseaserecruitstatisticstranscription factortumortumorigenesis
项目摘要
ABSTRACT
Obesity increases the risk for pancreatic ductal adenocarcinoma (PDA) by ~ 50% and mortality by more than
2-fold. Strikingly, PDA has the highest death rate among the most commonly diagnosed cancers, and with a
rising occurrence, it is predicted to become the 2nd leading cause of cancer deaths by 2020. The mechanisms
through which obesity promotes PDA are not well understood; however, the prevailing paradigm is that
obesity-associated stress and inflammatory markers play an essential role. Accordingly, stress stimuli
(hypoxia, oxidative-, nutrient-, biomechanical-stress, etc.) are thought to invoke the engagement of stress-
adaptive strategies by cancer cells to enhance their fitness. We have recently demonstrated that non-
membranous organelles termed stress granules, are a novel stress-coping machinery that is mobilized by
KRAS mutant PDA cells under stress to enhance tumor fitness and survival. Our preliminary data provide the
first lines of evidence indicating that stress granules are essential to the development of obesity-associated
PDA, and identified insulin growth factor-1 (IGF-1), a principal mediator of obesity-driven cancer, as a potent
inducer of stress granules. The goal of this proposal is to elucidate the mechanisms by which stress granules
promote obesity-associated PDA and to develop anti-stress granule chemopreventive approaches. We
propose to: 1) determine the role of IGF-1 in stress granule upregulation in obesity-associated PDA, 2)
decipher how stress granules promote obesity-associated PDA, and 3) target stress granules for the
chemoprevention of obesity-associated PDA. Collectively, these studies can establish stress granules as a
novel mechanism through which obesity promotes stress adaptation and PDA development, and inform the
development of new chemopreventive strategies.
摘要
肥胖使胰腺导管腺癌(PDA)的风险增加约50%,死亡率增加超过10%。
2倍。值得注意的是,PDA在最常见的癌症中死亡率最高,
发病率上升,预计到2020年将成为癌症死亡的第二大原因。的机制
肥胖促进PDA的机制尚不清楚;然而,流行的范式是,
肥胖相关的压力和炎症标记物起着重要作用。因此,压力刺激
(缺氧、氧化应激、营养应激、生物力学应激等)被认为是引发了压力的作用
癌细胞的适应性策略来增强它们的适应性。我们最近发现,非...
被称为应激颗粒的膜性细胞器是一种新型的应激应对机制,
KRAS突变PDA细胞在应激下增强肿瘤适应性和存活。我们的初步数据提供了
第一批证据表明,压力颗粒是必不可少的发展肥胖相关的
PDA,并确定胰岛素生长因子-1(IGF-1),肥胖驱动的癌症的主要介质,作为一种有效的
应激颗粒诱导剂。该提案的目标是阐明应激颗粒的机制
促进肥胖相关的PDA和开发抗应激颗粒化学预防方法。我们
建议:1)确定IGF-1在肥胖相关PDA中应激颗粒上调中的作用,2)
破译压力颗粒如何促进肥胖相关的PDA,和3)针对压力颗粒,
肥胖相关PDA的化学预防。总的来说,这些研究可以建立应力颗粒作为
肥胖促进压力适应和PDA发展的新机制,并为研究提供信息
开发新的化学预防策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elda Grabocka其他文献
Elda Grabocka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elda Grabocka', 18)}}的其他基金
Stress adaptation in obesity-associated pancreatic cancer
肥胖相关胰腺癌的压力适应
- 批准号:
10581170 - 财政年份:2023
- 资助金额:
$ 35.69万 - 项目类别:
Stress-adaptation in obesity-associated pancreatic cancer
肥胖相关胰腺癌的压力适应
- 批准号:
10415876 - 财政年份:2018
- 资助金额:
$ 35.69万 - 项目类别:
Stress-adaptation in obesity-associated pancreatic cancer
肥胖相关胰腺癌的压力适应
- 批准号:
10183195 - 财政年份:2018
- 资助金额:
$ 35.69万 - 项目类别:
Exploriing the role of oncogenic Ras in stress response mechanisms
探索致癌 Ras 在应激反应机制中的作用
- 批准号:
7753725 - 财政年份:2009
- 资助金额:
$ 35.69万 - 项目类别:
Exploriing the role of oncogenic Ras in stress response mechanisms
探索致癌 Ras 在应激反应机制中的作用
- 批准号:
7936093 - 财政年份:2009
- 资助金额:
$ 35.69万 - 项目类别:
相似海外基金
Assessing The Impact of Heparanase and NDST2 Expression on Non-Small Cell Lung Adenocarcinoma Cell Motility
评估乙酰肝素酶和 NDST2 表达对非小细胞肺腺癌细胞运动的影响
- 批准号:
449570 - 财政年份:2020
- 资助金额:
$ 35.69万 - 项目类别:
Studentship Programs
Analysis of cancer metastasis and invasion mechanism using a new lung adenocarcinoma cell line.
使用新的肺腺癌细胞系分析癌症转移和侵袭机制。
- 批准号:
16K10689 - 财政年份:2016
- 资助金额:
$ 35.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Acquisition strategy of tumor-specific markers using established micropapillary pattern pulmonary adenocarcinoma cell line
使用已建立的微乳头模式肺腺癌细胞系获取肿瘤特异性标志物的策略
- 批准号:
26460441 - 财政年份:2014
- 资助金额:
$ 35.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The antibetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
抗生素药物二甲双胍在体外和体内抑制食管腺癌细胞增殖。
- 批准号:
25860540 - 财政年份:2013
- 资助金额:
$ 35.69万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The cell permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferations and can be used as the molecular targeting dru
细胞通透肽抑制胰腺导管腺癌细胞增殖,可作为分子靶向药物
- 批准号:
25461969 - 财政年份:2013
- 资助金额:
$ 35.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic Research for elucidation of chemo-resistance in mucinous adenocarcinoma cell.
阐明粘液腺癌细胞化疗耐药性的基础研究。
- 批准号:
22791532 - 财政年份:2010
- 资助金额:
$ 35.69万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
TAS::75 0849::TAS IN THIS PHASE I SBIR THE BREAST CANCER ADENOCARCINOMA CELL LI
TAS::75 0849::TAS 在这一阶段 I SBIR 乳腺癌腺癌细胞 LI
- 批准号:
8164743 - 财政年份:2010
- 资助金额:
$ 35.69万 - 项目类别:
Role of Endothelin-1 in osteoblastic bone metastasis produced by a human lung adenocarcinoma cell line
Endothelin-1 在人肺腺癌细胞系产生的成骨细胞骨转移中的作用
- 批准号:
19790127 - 财政年份:2007
- 资助金额:
$ 35.69万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
CONNEXIN 43 EXPRESSION IN ADENOCARCINOMA CELL LINE
连接蛋白 43 在腺癌细胞系中的表达
- 批准号:
6972483 - 财政年份:2004
- 资助金额:
$ 35.69万 - 项目类别:
The mechanisms of highly metastetic capasity in highly metastatic subpopulations of lung adenocarcinoma cell line and these clinical applications
肺腺癌细胞系高转移亚群的高转移能力机制及临床应用
- 批准号:
15590831 - 财政年份:2003
- 资助金额:
$ 35.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




